Form 4: Praxis CFO's Routine Stock Withholding for Taxes

Praxis Precision Medicines' CFO, Timothy Kelly, reported a routine disposition of 139 common shares to cover tax obligations from vested restricted stock units.

Summary

• Timothy Edwin Kelly, Chief Financial Officer of Praxis Precision Medicines, Inc. (PRAX), reported a transaction on January 7, 2026.
• The transaction involved the disposition of 139 shares of Common Stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting of previously reported restricted stock units.
• The price per share for the withheld stock was $292.63.
• Following this transaction, Mr. Kelly beneficially owns 24,524 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction for tax withholding related to executive compensation, which is neutral in sentiment.

Positives

• The transaction is a routine administrative event, indicating the vesting of previously granted restricted stock units, which is a form of compensation.

Negatives

• No negative aspects are indicated by this routine tax withholding transaction.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing is a standard disclosure for insider transactions, specifically related to equity compensation and tax obligations, common across all publicly traded companies, particularly in the biotechnology and pharmaceutical sectors where equity incentives are prevalent.

Comparison to Industry Standards

• The practice of withholding shares to cover tax obligations upon the vesting of restricted stock units is a standard and widely accepted method of managing equity compensation in publicly traded companies, aligning with common corporate governance and compensation practices across industries.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine administrative transaction related to executive compensation, not a discretionary sale or a significant change in ownership structure.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Keywords

Praxis Precision Medicines, PRAX, Form 4, SEC filing, stock withholding, restricted stock units, CFO, insider transaction, equity compensation